Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for Marimed (MRMD) over the last 12 years, with Q3 2025 value amounting to -$1.7 million.

  • Marimed's Cash from Financing Activities fell 28582.33% to -$1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.7 million, marking a year-over-year decrease of 15564.57%. This contributed to the annual value of $3.0 million for FY2024, which is 8701.21% down from last year.
  • As of Q3 2025, Marimed's Cash from Financing Activities stood at -$1.7 million, which was down 28582.33% from -$806000.0 recorded in Q2 2025.
  • In the past 5 years, Marimed's Cash from Financing Activities registered a high of $23.3 million during Q1 2023, and its lowest value of -$3.1 million during Q3 2023.
  • Moreover, its 5-year median value for Cash from Financing Activities was -$286000.0 (2021), whereas its average is $1.5 million.
  • Per our database at Business Quant, Marimed's Cash from Financing Activities crashed by 134915.25% in 2022 and then soared by 717659.57% in 2023.
  • Marimed's Cash from Financing Activities (Quarter) stood at -$286000.0 in 2021, then tumbled by 109.79% to -$600000.0 in 2022, then soared by 850.0% to $4.5 million in 2023, then crashed by 119.84% to -$893000.0 in 2024, then crashed by 90.82% to -$1.7 million in 2025.
  • Its Cash from Financing Activities was -$1.7 million in Q3 2025, compared to -$806000.0 in Q2 2025 and -$1.3 million in Q1 2025.